Skip to main content

Table 1 The Characteristics of three patients with retinal arterial macroaneurysm

From: Intravitreal ranibizumab or conbercept for retinal arterial macroaneurysm: a case series

Case

Age (years)

Sex

Eye

Medical history

Lesion location

Fovea

Anti-VEGF injection

Follow-up (months)

BCVA

CMT(μm)

baseline

final

baseline

final

1

69

female

left

HT

supra-temporal

IRH, SRD

ranibizumab # 2

12

20/70

20/30

392

205

2

76

female

right

HT

infra-temporal

IRH, SRD

ranibizumab #2

12

20/200

20/50

465

183

3

62

female

left

HT

infra-temporal

PRH

conbercept #1

6

CF

20/40

799

313

  1. HT hypertension, IRH intra-retinal hemorrhage, PRH pre-retinal hemorrhage, SRD serous retinal detachment, BCVA best-corrected visual acuity, CF counting fingers, CMT central macular thickness